To determine whether TPD52L2 affects the malignant biological behavior of ccRCC cell lines, we first confirmed the relative upregulation of TPD52L2 expression in the renal clear cell carcinoma cell line 786-O using RT-qPCR (Figure 12A). Here, TPD52L2 is linked to nonpapillary renal cell carcinoma.